Treatment Monitoring in Multiple Sclerosis — Efficacy and Safety

IF 1.3 4区医学 Q4 NEUROIMAGING

Neuroimaging Clinics of North America Pub Date : 2024-04-29 DOI:10.1016/j.nic.2024.03.009

Nima Mahmoudi MD , Mike P. Wattjes MD, PhD

引用次数: 0

查看原文本刊更多论文

多发性硬化症的治疗监控--疗效与安全性。

磁共振成像是检测多发性硬化症炎症活动最灵敏的方法，尤其是在大脑中，它能显示亚临床炎症。已有的磁共振成像标记包括对比增强病变和活跃的 T2 病变。目前正在探索新的有前途的标记物，如缓慢扩大的病变和相缘病变，以监测慢性炎症，但临床应用还需要进一步验证。体积和定量 MRI 技术目前仅限于临床试验，尚未被推荐用于常规临床应用。此外，核磁共振成像对于检测疾病改变治疗的并发症以及实施基于核磁共振成像的药物警戒策略（如对接受纳他珠单抗治疗的患者）至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neuroimaging Clinics of North America 医学-核医学

CiteScore

4.10

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Published four times a year—February, May, August, and November—Neuroimaging Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in neuroimaging and is presented under the direction of an experienced editor. Topics include brain and spine, head and neck, vascular, nerves, pediatric, movement disorders, and dementia. In addition, you can also purchase a CME subscription that offers up to 60 AMA Category 1 credits per year.